What is the projected market valuation for the Intravenous IV Therapy and Vein Access Market in 2035?

The projected market valuation for the Intravenous IV Therapy and Vein Access Market in 2035 is 52.69 USD Billion. Read More

What was the market valuation for the Intravenous IV Therapy and Vein Access Market in 2024?

The market valuation for the Intravenous IV Therapy and Vein Access Market in 2024 was 34.19 USD Billion. Read More

What is the expected CAGR for the Intravenous IV Therapy and Vein Access Market during the forecast period 2025 - 2035?

The expected CAGR for the Intravenous IV Therapy and Vein Access Market during the forecast period 2025 - 2035 is 4.01%. Read More

Which companies are considered key players in the Intravenous IV Therapy and Vein Access Market?

Key players in the market include Becton Dickinson and Company, Fresenius Kabi AG, Smiths Medical, and Medtronic plc. Read More

What are the projected values for Continuous IV Therapy by 2035?

The projected value for Continuous IV Therapy by 2035 is expected to reach 15.0 USD Billion. Read More

How does the market for Peripheral IV Catheters compare to Central Venous Catheters in 2035?

By 2035, the market for Peripheral IV Catheters is projected to be 15.0 USD Billion, while Central Venous Catheters may reach 18.0 USD Billion. Read More

What is the anticipated market size for Fluid Replacement applications by 2035?

The anticipated market size for Fluid Replacement applications by 2035 is 21.69 USD Billion. Read More

What is the projected market value for Adult Patients in the Intravenous IV Therapy and Vein Access Market by 2035?

The projected market value for Adult Patients by 2035 is expected to be 30.0 USD Billion. Read More

What are the expected values for Intraosseous administration routes by 2035?

The expected value for Intraosseous administration routes by 2035 is projected to be 11.69 USD Billion. Read More

What is the market outlook for Pain Management applications in 2035?

The market outlook for Pain Management applications in 2035 suggests a value of 9.0 USD Billion. Read More

Intravenous Therapy Vein Acces Market

ID: MRFR/HC/30731-HCR

100 Pages

Rahul Gotadki

Last Updated: April 06, 2026

Intravenous IV Therapy and Vein Access Market Research Report By IV Therapy Type (Continuous IV Therapy, Intermittent IV Therapy, IV Push Therapy), By Vein Access Device Type (Peripheral IV Catheters, Central Venous Catheters, Midline Catheters), By Application Area (Oncology, Infectious Diseases, Pain Management, Fluid Replacement), By Patient Type (Pediatric Patients, Adult Patients, Geriatric Patients), By Administration Route (Intravenous, Intraosseous) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035

Intravenous Therapy Vein Acces Market Infographic

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1.1 EXECUTIVE SUMMARY
1.1.1 Market Overview
1.1.2 Key Findings
1.1.3 Market Segmentation
1.1.4 Competitive Landscape
1.1.5 Challenges and Opportunities
1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
2.1 MARKET INTRODUCTION
2.1.1 Definition
2.1.2 Scope of the study
2.1.2.1 Research Objective
2.1.2.2 Assumption
2.1.2.3 Limitations
2.2 RESEARCH METHODOLOGY
2.2.1 Overview
2.2.2 Data Mining
2.2.3 Secondary Research
2.2.4 Primary Research
2.2.4.1 Primary Interviews and Information Gathering Process
2.2.4.2 Breakdown of Primary Respondents
2.2.5 Forecasting Model
2.2.6 Market Size Estimation
2.2.6.1 Bottom-Up Approach
2.2.6.2 Top-Down Approach
2.2.7 Data Triangulation
2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
3.1 MARKET DYNAMICS
3.1.1 Overview
3.1.2 Drivers
3.1.3 Restraints
3.1.4 Opportunities
3.2 MARKET FACTOR ANALYSIS
3.2.1 Value chain Analysis
3.2.2 Porter's Five Forces Analysis
3.2.2.1 Bargaining Power of Suppliers
3.2.2.2 Bargaining Power of Buyers
3.2.2.3 Threat of New Entrants
3.2.2.4 Threat of Substitutes
3.2.2.5 Intensity of Rivalry
3.2.3 COVID-19 Impact Analysis
3.2.3.1 Market Impact Analysis
3.2.3.2 Regional Impact
3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
4.1 Healthcare, BY IV Therapy Type (USD Billion)
4.1.1 Continuous IV Therapy
4.1.2 Intermittent IV Therapy
4.1.3 IV Push Therapy
4.2 Healthcare, BY Vein Access Device Type (USD Billion)
4.2.1 Peripheral IV Catheters
4.2.2 Central Venous Catheters
4.2.3 Midline Catheters
4.3 Healthcare, BY Application Area (USD Billion)
4.3.1 Oncology
4.3.2 Infectious Diseases
4.3.3 Pain Management
4.3.4 Fluid Replacement
4.4 Healthcare, BY Patient Type (USD Billion)
4.4.1 Pediatric Patients
4.4.2 Adult Patients
4.4.3 Geriatric Patients
4.5 Healthcare, BY Administration Route (USD Billion)
4.5.1 Intravenous
4.5.2 Intraosseous
4.6 Healthcare, BY Region (USD Billion)
4.6.1 North America
4.6.1.1 US
4.6.1.2 Canada
4.6.2 Europe
4.6.2.1 Germany
4.6.2.2 UK
4.6.2.3 France
4.6.2.4 Russia
4.6.2.5 Italy
4.6.2.6 Spain
4.6.2.7 Rest of Europe
4.6.3 APAC
4.6.3.1 China
4.6.3.2 India
4.6.3.3 Japan
4.6.3.4 South Korea
4.6.3.5 Malaysia
4.6.3.6 Thailand
4.6.3.7 Indonesia
4.6.3.8 Rest of APAC
4.6.4 South America
4.6.4.1 Brazil
4.6.4.2 Mexico
4.6.4.3 Argentina
4.6.4.4 Rest of South America
4.6.5 MEA
4.6.5.1 GCC Countries
4.6.5.2 South Africa
4.6.5.3 Rest of MEA
5 SECTION V: COMPETITIVE ANALYSIS
5.1 Competitive Landscape
5.1.1 Overview
5.1.2 Competitive Analysis
5.1.3 Market share Analysis
5.1.4 Major Growth Strategy in the Healthcare
5.1.5 Competitive Benchmarking
5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
5.1.7 Key developments and growth strategies
5.1.7.1 New Product Launch/Service Deployment
5.1.7.2 Merger & Acquisitions
5.1.7.3 Joint Ventures
5.1.8 Major Players Financial Matrix
5.1.8.1 Sales and Operating Income
5.1.8.2 Major Players R&D Expenditure. 2023
5.2 Company Profiles
5.2.1 Becton Dickinson and Company (US)
5.2.1.1 Financial Overview
5.2.1.2 Products Offered
5.2.1.3 Key Developments
5.2.1.4 SWOT Analysis
5.2.1.5 Key Strategies
5.2.2 Fresenius Kabi AG (DE)
5.2.2.1 Financial Overview
5.2.2.2 Products Offered
5.2.2.3 Key Developments
5.2.2.4 SWOT Analysis
5.2.2.5 Key Strategies
5.2.3 Smiths Medical (US)
5.2.3.1 Financial Overview
5.2.3.2 Products Offered
5.2.3.3 Key Developments
5.2.3.4 SWOT Analysis
5.2.3.5 Key Strategies
5.2.4 Terumo Corporation (JP)
5.2.4.1 Financial Overview
5.2.4.2 Products Offered
5.2.4.3 Key Developments
5.2.4.4 SWOT Analysis
5.2.4.5 Key Strategies
5.2.5 Medtronic plc (IE)
5.2.5.1 Financial Overview
5.2.5.2 Products Offered
5.2.5.3 Key Developments
5.2.5.4 SWOT Analysis
5.2.5.5 Key Strategies
5.2.6 Vygon S.A. (FR)
5.2.6.1 Financial Overview
5.2.6.2 Products Offered
5.2.6.3 Key Developments
5.2.6.4 SWOT Analysis
5.2.6.5 Key Strategies
5.2.7 AngioDynamics, Inc. (US)
5.2.7.1 Financial Overview
5.2.7.2 Products Offered
5.2.7.3 Key Developments
5.2.7.4 SWOT Analysis
5.2.7.5 Key Strategies
5.2.8 B. Braun Melsungen AG (DE)
5.2.8.1 Financial Overview
5.2.8.2 Products Offered
5.2.8.3 Key Developments
5.2.8.4 SWOT Analysis
5.2.8.5 Key Strategies
5.2.9 Teleflex Incorporated (US)
5.2.9.1 Financial Overview
5.2.9.2 Products Offered
5.2.9.3 Key Developments
5.2.9.4 SWOT Analysis
5.2.9.5 Key Strategies
5.3 Appendix
5.3.1 References
5.3.2 Related Reports
6 LIST OF FIGURES
6.1 MARKET SYNOPSIS
6.2 NORTH AMERICA MARKET ANALYSIS
6.3 US MARKET ANALYSIS BY IV THERAPY TYPE
6.4 US MARKET ANALYSIS BY VEIN ACCESS DEVICE TYPE
6.5 US MARKET ANALYSIS BY APPLICATION AREA
6.6 US MARKET ANALYSIS BY PATIENT TYPE
6.7 US MARKET ANALYSIS BY ADMINISTRATION ROUTE
6.8 CANADA MARKET ANALYSIS BY IV THERAPY TYPE
6.9 CANADA MARKET ANALYSIS BY VEIN ACCESS DEVICE TYPE
6.10 CANADA MARKET ANALYSIS BY APPLICATION AREA
6.11 CANADA MARKET ANALYSIS BY PATIENT TYPE
6.12 CANADA MARKET ANALYSIS BY ADMINISTRATION ROUTE
6.13 EUROPE MARKET ANALYSIS
6.14 GERMANY MARKET ANALYSIS BY IV THERAPY TYPE
6.15 GERMANY MARKET ANALYSIS BY VEIN ACCESS DEVICE TYPE
6.16 GERMANY MARKET ANALYSIS BY APPLICATION AREA
6.17 GERMANY MARKET ANALYSIS BY PATIENT TYPE
6.18 GERMANY MARKET ANALYSIS BY ADMINISTRATION ROUTE
6.19 UK MARKET ANALYSIS BY IV THERAPY TYPE
6.20 UK MARKET ANALYSIS BY VEIN ACCESS DEVICE TYPE
6.21 UK MARKET ANALYSIS BY APPLICATION AREA
6.22 UK MARKET ANALYSIS BY PATIENT TYPE
6.23 UK MARKET ANALYSIS BY ADMINISTRATION ROUTE
6.24 FRANCE MARKET ANALYSIS BY IV THERAPY TYPE
6.25 FRANCE MARKET ANALYSIS BY VEIN ACCESS DEVICE TYPE
6.26 FRANCE MARKET ANALYSIS BY APPLICATION AREA
6.27 FRANCE MARKET ANALYSIS BY PATIENT TYPE
6.28 FRANCE MARKET ANALYSIS BY ADMINISTRATION ROUTE
6.29 RUSSIA MARKET ANALYSIS BY IV THERAPY TYPE
6.30 RUSSIA MARKET ANALYSIS BY VEIN ACCESS DEVICE TYPE
6.31 RUSSIA MARKET ANALYSIS BY APPLICATION AREA
6.32 RUSSIA MARKET ANALYSIS BY PATIENT TYPE
6.33 RUSSIA MARKET ANALYSIS BY ADMINISTRATION ROUTE
6.34 ITALY MARKET ANALYSIS BY IV THERAPY TYPE
6.35 ITALY MARKET ANALYSIS BY VEIN ACCESS DEVICE TYPE
6.36 ITALY MARKET ANALYSIS BY APPLICATION AREA
6.37 ITALY MARKET ANALYSIS BY PATIENT TYPE
6.38 ITALY MARKET ANALYSIS BY ADMINISTRATION ROUTE
6.39 SPAIN MARKET ANALYSIS BY IV THERAPY TYPE
6.40 SPAIN MARKET ANALYSIS BY VEIN ACCESS DEVICE TYPE
6.41 SPAIN MARKET ANALYSIS BY APPLICATION AREA
6.42 SPAIN MARKET ANALYSIS BY PATIENT TYPE
6.43 SPAIN MARKET ANALYSIS BY ADMINISTRATION ROUTE
6.44 REST OF EUROPE MARKET ANALYSIS BY IV THERAPY TYPE
6.45 REST OF EUROPE MARKET ANALYSIS BY VEIN ACCESS DEVICE TYPE
6.46 REST OF EUROPE MARKET ANALYSIS BY APPLICATION AREA
6.47 REST OF EUROPE MARKET ANALYSIS BY PATIENT TYPE
6.48 REST OF EUROPE MARKET ANALYSIS BY ADMINISTRATION ROUTE
6.49 APAC MARKET ANALYSIS
6.50 CHINA MARKET ANALYSIS BY IV THERAPY TYPE
6.51 CHINA MARKET ANALYSIS BY VEIN ACCESS DEVICE TYPE
6.52 CHINA MARKET ANALYSIS BY APPLICATION AREA
6.53 CHINA MARKET ANALYSIS BY PATIENT TYPE
6.54 CHINA MARKET ANALYSIS BY ADMINISTRATION ROUTE
6.55 INDIA MARKET ANALYSIS BY IV THERAPY TYPE
6.56 INDIA MARKET ANALYSIS BY VEIN ACCESS DEVICE TYPE
6.57 INDIA MARKET ANALYSIS BY APPLICATION AREA
6.58 INDIA MARKET ANALYSIS BY PATIENT TYPE
6.59 INDIA MARKET ANALYSIS BY ADMINISTRATION ROUTE
6.60 JAPAN MARKET ANALYSIS BY IV THERAPY TYPE
6.61 JAPAN MARKET ANALYSIS BY VEIN ACCESS DEVICE TYPE
6.62 JAPAN MARKET ANALYSIS BY APPLICATION AREA
6.63 JAPAN MARKET ANALYSIS BY PATIENT TYPE
6.64 JAPAN MARKET ANALYSIS BY ADMINISTRATION ROUTE
6.65 SOUTH KOREA MARKET ANALYSIS BY IV THERAPY TYPE
6.66 SOUTH KOREA MARKET ANALYSIS BY VEIN ACCESS DEVICE TYPE
6.67 SOUTH KOREA MARKET ANALYSIS BY APPLICATION AREA
6.68 SOUTH KOREA MARKET ANALYSIS BY PATIENT TYPE
6.69 SOUTH KOREA MARKET ANALYSIS BY ADMINISTRATION ROUTE
6.70 MALAYSIA MARKET ANALYSIS BY IV THERAPY TYPE
6.71 MALAYSIA MARKET ANALYSIS BY VEIN ACCESS DEVICE TYPE
6.72 MALAYSIA MARKET ANALYSIS BY APPLICATION AREA
6.73 MALAYSIA MARKET ANALYSIS BY PATIENT TYPE
6.74 MALAYSIA MARKET ANALYSIS BY ADMINISTRATION ROUTE
6.75 THAILAND MARKET ANALYSIS BY IV THERAPY TYPE
6.76 THAILAND MARKET ANALYSIS BY VEIN ACCESS DEVICE TYPE
6.77 THAILAND MARKET ANALYSIS BY APPLICATION AREA
6.78 THAILAND MARKET ANALYSIS BY PATIENT TYPE
6.79 THAILAND MARKET ANALYSIS BY ADMINISTRATION ROUTE
6.80 INDONESIA MARKET ANALYSIS BY IV THERAPY TYPE
6.81 INDONESIA MARKET ANALYSIS BY VEIN ACCESS DEVICE TYPE
6.82 INDONESIA MARKET ANALYSIS BY APPLICATION AREA
6.83 INDONESIA MARKET ANALYSIS BY PATIENT TYPE
6.84 INDONESIA MARKET ANALYSIS BY ADMINISTRATION ROUTE
6.85 REST OF APAC MARKET ANALYSIS BY IV THERAPY TYPE
6.86 REST OF APAC MARKET ANALYSIS BY VEIN ACCESS DEVICE TYPE
6.87 REST OF APAC MARKET ANALYSIS BY APPLICATION AREA
6.88 REST OF APAC MARKET ANALYSIS BY PATIENT TYPE
6.89 REST OF APAC MARKET ANALYSIS BY ADMINISTRATION ROUTE
6.90 SOUTH AMERICA MARKET ANALYSIS
6.91 BRAZIL MARKET ANALYSIS BY IV THERAPY TYPE
6.92 BRAZIL MARKET ANALYSIS BY VEIN ACCESS DEVICE TYPE
6.93 BRAZIL MARKET ANALYSIS BY APPLICATION AREA
6.94 BRAZIL MARKET ANALYSIS BY PATIENT TYPE
6.95 BRAZIL MARKET ANALYSIS BY ADMINISTRATION ROUTE
6.96 MEXICO MARKET ANALYSIS BY IV THERAPY TYPE
6.97 MEXICO MARKET ANALYSIS BY VEIN ACCESS DEVICE TYPE
6.98 MEXICO MARKET ANALYSIS BY APPLICATION AREA
6.99 MEXICO MARKET ANALYSIS BY PATIENT TYPE
6.100 MEXICO MARKET ANALYSIS BY ADMINISTRATION ROUTE
6.101 ARGENTINA MARKET ANALYSIS BY IV THERAPY TYPE
6.102 ARGENTINA MARKET ANALYSIS BY VEIN ACCESS DEVICE TYPE
6.103 ARGENTINA MARKET ANALYSIS BY APPLICATION AREA
6.104 ARGENTINA MARKET ANALYSIS BY PATIENT TYPE
6.105 ARGENTINA MARKET ANALYSIS BY ADMINISTRATION ROUTE
6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY IV THERAPY TYPE
6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY VEIN ACCESS DEVICE TYPE
6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION AREA
6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY PATIENT TYPE
6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY ADMINISTRATION ROUTE
6.111 MEA MARKET ANALYSIS
6.112 GCC COUNTRIES MARKET ANALYSIS BY IV THERAPY TYPE
6.113 GCC COUNTRIES MARKET ANALYSIS BY VEIN ACCESS DEVICE TYPE
6.114 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION AREA
6.115 GCC COUNTRIES MARKET ANALYSIS BY PATIENT TYPE
6.116 GCC COUNTRIES MARKET ANALYSIS BY ADMINISTRATION ROUTE
6.117 SOUTH AFRICA MARKET ANALYSIS BY IV THERAPY TYPE
6.118 SOUTH AFRICA MARKET ANALYSIS BY VEIN ACCESS DEVICE TYPE
6.119 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION AREA
6.120 SOUTH AFRICA MARKET ANALYSIS BY PATIENT TYPE
6.121 SOUTH AFRICA MARKET ANALYSIS BY ADMINISTRATION ROUTE
6.122 REST OF MEA MARKET ANALYSIS BY IV THERAPY TYPE
6.123 REST OF MEA MARKET ANALYSIS BY VEIN ACCESS DEVICE TYPE
6.124 REST OF MEA MARKET ANALYSIS BY APPLICATION AREA
6.125 REST OF MEA MARKET ANALYSIS BY PATIENT TYPE
6.126 REST OF MEA MARKET ANALYSIS BY ADMINISTRATION ROUTE
6.127 KEY BUYING CRITERIA OF HEALTHCARE
6.128 RESEARCH PROCESS OF MRFR
6.129 DRO ANALYSIS OF HEALTHCARE
6.130 DRIVERS IMPACT ANALYSIS: HEALTHCARE
6.131 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
6.132 SUPPLY / VALUE CHAIN: HEALTHCARE
6.133 HEALTHCARE, BY IV THERAPY TYPE, 2024 (% SHARE)
6.134 HEALTHCARE, BY IV THERAPY TYPE, 2024 TO 2035 (USD Billion)
6.135 HEALTHCARE, BY VEIN ACCESS DEVICE TYPE, 2024 (% SHARE)
6.136 HEALTHCARE, BY VEIN ACCESS DEVICE TYPE, 2024 TO 2035 (USD Billion)
6.137 HEALTHCARE, BY APPLICATION AREA, 2024 (% SHARE)
6.138 HEALTHCARE, BY APPLICATION AREA, 2024 TO 2035 (USD Billion)
6.139 HEALTHCARE, BY PATIENT TYPE, 2024 (% SHARE)
6.140 HEALTHCARE, BY PATIENT TYPE, 2024 TO 2035 (USD Billion)
6.141 HEALTHCARE, BY ADMINISTRATION ROUTE, 2024 (% SHARE)
6.142 HEALTHCARE, BY ADMINISTRATION ROUTE, 2024 TO 2035 (USD Billion)
6.143 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
7.1 LIST OF ASSUMPTIONS
7.1.1
7.2 North America MARKET SIZE ESTIMATES; FORECAST
7.2.1 BY IV THERAPY TYPE, 2025-2035 (USD Billion)
7.2.2 BY VEIN ACCESS DEVICE TYPE, 2025-2035 (USD Billion)
7.2.3 BY APPLICATION AREA, 2025-2035 (USD Billion)
7.2.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
7.2.5 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
7.3 US MARKET SIZE ESTIMATES; FORECAST
7.3.1 BY IV THERAPY TYPE, 2025-2035 (USD Billion)
7.3.2 BY VEIN ACCESS DEVICE TYPE, 2025-2035 (USD Billion)
7.3.3 BY APPLICATION AREA, 2025-2035 (USD Billion)
7.3.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
7.3.5 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
7.4 Canada MARKET SIZE ESTIMATES; FORECAST
7.4.1 BY IV THERAPY TYPE, 2025-2035 (USD Billion)
7.4.2 BY VEIN ACCESS DEVICE TYPE, 2025-2035 (USD Billion)
7.4.3 BY APPLICATION AREA, 2025-2035 (USD Billion)
7.4.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
7.4.5 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
7.5 Europe MARKET SIZE ESTIMATES; FORECAST
7.5.1 BY IV THERAPY TYPE, 2025-2035 (USD Billion)
7.5.2 BY VEIN ACCESS DEVICE TYPE, 2025-2035 (USD Billion)
7.5.3 BY APPLICATION AREA, 2025-2035 (USD Billion)
7.5.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
7.5.5 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
7.6 Germany MARKET SIZE ESTIMATES; FORECAST
7.6.1 BY IV THERAPY TYPE, 2025-2035 (USD Billion)
7.6.2 BY VEIN ACCESS DEVICE TYPE, 2025-2035 (USD Billion)
7.6.3 BY APPLICATION AREA, 2025-2035 (USD Billion)
7.6.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
7.6.5 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
7.7 UK MARKET SIZE ESTIMATES; FORECAST
7.7.1 BY IV THERAPY TYPE, 2025-2035 (USD Billion)
7.7.2 BY VEIN ACCESS DEVICE TYPE, 2025-2035 (USD Billion)
7.7.3 BY APPLICATION AREA, 2025-2035 (USD Billion)
7.7.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
7.7.5 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
7.8 France MARKET SIZE ESTIMATES; FORECAST
7.8.1 BY IV THERAPY TYPE, 2025-2035 (USD Billion)
7.8.2 BY VEIN ACCESS DEVICE TYPE, 2025-2035 (USD Billion)
7.8.3 BY APPLICATION AREA, 2025-2035 (USD Billion)
7.8.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
7.8.5 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
7.9 Russia MARKET SIZE ESTIMATES; FORECAST
7.9.1 BY IV THERAPY TYPE, 2025-2035 (USD Billion)
7.9.2 BY VEIN ACCESS DEVICE TYPE, 2025-2035 (USD Billion)
7.9.3 BY APPLICATION AREA, 2025-2035 (USD Billion)
7.9.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
7.9.5 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
7.10 Italy MARKET SIZE ESTIMATES; FORECAST
7.10.1 BY IV THERAPY TYPE, 2025-2035 (USD Billion)
7.10.2 BY VEIN ACCESS DEVICE TYPE, 2025-2035 (USD Billion)
7.10.3 BY APPLICATION AREA, 2025-2035 (USD Billion)
7.10.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
7.10.5 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
7.11 Spain MARKET SIZE ESTIMATES; FORECAST
7.11.1 BY IV THERAPY TYPE, 2025-2035 (USD Billion)
7.11.2 BY VEIN ACCESS DEVICE TYPE, 2025-2035 (USD Billion)
7.11.3 BY APPLICATION AREA, 2025-2035 (USD Billion)
7.11.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
7.11.5 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
7.12.1 BY IV THERAPY TYPE, 2025-2035 (USD Billion)
7.12.2 BY VEIN ACCESS DEVICE TYPE, 2025-2035 (USD Billion)
7.12.3 BY APPLICATION AREA, 2025-2035 (USD Billion)
7.12.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
7.12.5 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
7.13 APAC MARKET SIZE ESTIMATES; FORECAST
7.13.1 BY IV THERAPY TYPE, 2025-2035 (USD Billion)
7.13.2 BY VEIN ACCESS DEVICE TYPE, 2025-2035 (USD Billion)
7.13.3 BY APPLICATION AREA, 2025-2035 (USD Billion)
7.13.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
7.13.5 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
7.14 China MARKET SIZE ESTIMATES; FORECAST
7.14.1 BY IV THERAPY TYPE, 2025-2035 (USD Billion)
7.14.2 BY VEIN ACCESS DEVICE TYPE, 2025-2035 (USD Billion)
7.14.3 BY APPLICATION AREA, 2025-2035 (USD Billion)
7.14.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
7.14.5 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
7.15 India MARKET SIZE ESTIMATES; FORECAST
7.15.1 BY IV THERAPY TYPE, 2025-2035 (USD Billion)
7.15.2 BY VEIN ACCESS DEVICE TYPE, 2025-2035 (USD Billion)
7.15.3 BY APPLICATION AREA, 2025-2035 (USD Billion)
7.15.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
7.15.5 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
7.16 Japan MARKET SIZE ESTIMATES; FORECAST
7.16.1 BY IV THERAPY TYPE, 2025-2035 (USD Billion)
7.16.2 BY VEIN ACCESS DEVICE TYPE, 2025-2035 (USD Billion)
7.16.3 BY APPLICATION AREA, 2025-2035 (USD Billion)
7.16.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
7.16.5 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
7.17.1 BY IV THERAPY TYPE, 2025-2035 (USD Billion)
7.17.2 BY VEIN ACCESS DEVICE TYPE, 2025-2035 (USD Billion)
7.17.3 BY APPLICATION AREA, 2025-2035 (USD Billion)
7.17.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
7.17.5 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
7.18.1 BY IV THERAPY TYPE, 2025-2035 (USD Billion)
7.18.2 BY VEIN ACCESS DEVICE TYPE, 2025-2035 (USD Billion)
7.18.3 BY APPLICATION AREA, 2025-2035 (USD Billion)
7.18.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
7.18.5 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
7.19.1 BY IV THERAPY TYPE, 2025-2035 (USD Billion)
7.19.2 BY VEIN ACCESS DEVICE TYPE, 2025-2035 (USD Billion)
7.19.3 BY APPLICATION AREA, 2025-2035 (USD Billion)
7.19.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
7.19.5 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
7.20.1 BY IV THERAPY TYPE, 2025-2035 (USD Billion)
7.20.2 BY VEIN ACCESS DEVICE TYPE, 2025-2035 (USD Billion)
7.20.3 BY APPLICATION AREA, 2025-2035 (USD Billion)
7.20.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
7.20.5 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
7.21.1 BY IV THERAPY TYPE, 2025-2035 (USD Billion)
7.21.2 BY VEIN ACCESS DEVICE TYPE, 2025-2035 (USD Billion)
7.21.3 BY APPLICATION AREA, 2025-2035 (USD Billion)
7.21.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
7.21.5 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
7.22 South America MARKET SIZE ESTIMATES; FORECAST
7.22.1 BY IV THERAPY TYPE, 2025-2035 (USD Billion)
7.22.2 BY VEIN ACCESS DEVICE TYPE, 2025-2035 (USD Billion)
7.22.3 BY APPLICATION AREA, 2025-2035 (USD Billion)
7.22.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
7.22.5 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
7.23.1 BY IV THERAPY TYPE, 2025-2035 (USD Billion)
7.23.2 BY VEIN ACCESS DEVICE TYPE, 2025-2035 (USD Billion)
7.23.3 BY APPLICATION AREA, 2025-2035 (USD Billion)
7.23.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
7.23.5 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
7.24.1 BY IV THERAPY TYPE, 2025-2035 (USD Billion)
7.24.2 BY VEIN ACCESS DEVICE TYPE, 2025-2035 (USD Billion)
7.24.3 BY APPLICATION AREA, 2025-2035 (USD Billion)
7.24.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
7.24.5 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
7.25.1 BY IV THERAPY TYPE, 2025-2035 (USD Billion)
7.25.2 BY VEIN ACCESS DEVICE TYPE, 2025-2035 (USD Billion)
7.25.3 BY APPLICATION AREA, 2025-2035 (USD Billion)
7.25.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
7.25.5 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
7.26.1 BY IV THERAPY TYPE, 2025-2035 (USD Billion)
7.26.2 BY VEIN ACCESS DEVICE TYPE, 2025-2035 (USD Billion)
7.26.3 BY APPLICATION AREA, 2025-2035 (USD Billion)
7.26.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
7.26.5 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
7.27 MEA MARKET SIZE ESTIMATES; FORECAST
7.27.1 BY IV THERAPY TYPE, 2025-2035 (USD Billion)
7.27.2 BY VEIN ACCESS DEVICE TYPE, 2025-2035 (USD Billion)
7.27.3 BY APPLICATION AREA, 2025-2035 (USD Billion)
7.27.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
7.27.5 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
7.28.1 BY IV THERAPY TYPE, 2025-2035 (USD Billion)
7.28.2 BY VEIN ACCESS DEVICE TYPE, 2025-2035 (USD Billion)
7.28.3 BY APPLICATION AREA, 2025-2035 (USD Billion)
7.28.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
7.28.5 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
7.29.1 BY IV THERAPY TYPE, 2025-2035 (USD Billion)
7.29.2 BY VEIN ACCESS DEVICE TYPE, 2025-2035 (USD Billion)
7.29.3 BY APPLICATION AREA, 2025-2035 (USD Billion)
7.29.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
7.29.5 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
7.30.1 BY IV THERAPY TYPE, 2025-2035 (USD Billion)
7.30.2 BY VEIN ACCESS DEVICE TYPE, 2025-2035 (USD Billion)
7.30.3 BY APPLICATION AREA, 2025-2035 (USD Billion)
7.30.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
7.30.5 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.31.1
7.32 ACQUISITION/PARTNERSHIP
7.32.1

Certified Researchers

Customize Report

Healthcare Market Segmentation

Healthcare By IV Therapy Type (USD Billion, 2025-2035)

Continuous IV Therapy
Intermittent IV Therapy
IV Push Therapy

Healthcare By Vein Access Device Type (USD Billion, 2025-2035)

Peripheral IV Catheters
Central Venous Catheters
Midline Catheters

Healthcare By Application Area (USD Billion, 2025-2035)

Oncology
Infectious Diseases
Pain Management
Fluid Replacement

Healthcare By Patient Type (USD Billion, 2025-2035)

Pediatric Patients
Adult Patients
Geriatric Patients

Healthcare By Administration Route (USD Billion, 2025-2035)

Intravenous
Intraosseous

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Features	License Type
Features	Single User	Multiuser License	Enterprise User
Price	$4,950	$5,950	$7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout the Organization
Free Customization	✓	✓	✓
Direct Access to Analyst	✓	✓	✓
Deliverable Format	✓	✓	✓
Platform Access	✗	✗	✓
Discount on Next Purchase	10%	15%	15%
Printable Versions	✗	✗	✓